Evaluation of lymph nodes with RECIST 1.1

Published:December 17, 2008DOI:


      Lymph nodes are common sites of metastatic disease in many solid tumours. Unlike most metastases, lymph nodes are normal anatomic structures and as such, normal lymph nodes will have a measurable size. Additionally, the imaging literature recommends that lymph nodes be measured in the short axis, since the short axis measurement is a more reproducible measurement and predictive of malignancy. Therefore, the RECIST committee recommends that lymph nodes be measured in their short axis and proposes measurement values and rules for categorising lymph nodes as normal or pathologic; either target or non-target lesions. Data for the RECIST warehouse are presented to demonstrate the potential change in response assessment following these rules. These standardised lymph node guidelines are designed to be easy to implement, focus target lesion measurements on lesions that are likely to be metastatic and prevent false progressions due to minimal change in size.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to European Journal of Cancer
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Einstein D.M.
        • Singer A.A.
        • Chilcote W.A.
        • Desai R.K.
        Abdominal lymphadenopathy: spectrum of CT findings.
        Radiographics. 1991; 11: 457-472
        • Castellino R.A.
        • Marglin S.I.
        Imaging of abdominal and pelvic lymph nodes: lymphography or computed tomography?.
        Invest Radiol. 1982; 17: 433-443
        • Steinkamp H.
        • Cornhel M.
        • Hosten N.
        • et al.
        Cervical lymphopathy: ration of long to short-axis diameter as a predictor for malignancy.
        Br J Radiol. 1995; 68: 266-270
        • Steinkamp H.J.
        • Hosten N.
        • Richter C.
        • Schedel H.
        • Felix R.
        Enlarged cervical lymph nodes at helical CT.
        Radiology. 1994; 191: 795-798
        • Glazer G.M.
        • Gross B.H.
        • Quint L.E.
        • Francis I.R.
        • Bookstein F.L.
        • Orringer M.B.
        Normal mediastinal lymph nodes: number and size according to American Thoracic Society mapping.
        AJR Am J Roentgenol. 1985; 144: 261-265
        • Matsuoka H.
        • Masaki T.
        • Sugiyama M.
        • Atomi Y.
        • Ohkura Y.
        • Sakamoto A.
        Morphological characteristics of lateral pelvic lymph nodes in rectal carcinoma.
        Langenbecks Arch Surg. 2007; 392: 543-547
        • Bogaerts J.
        • Ford R.
        • Sargent D.
        • et al.
        Individual patient data analysis to assess modifications to the RECIST criteria.
        Eur J Cancer. 2009; 45: 248-260
        • Eisenhauer E.A.
        • Therasse P.
        • Bogaerts J.
        • et al.
        New response evaluation criteria in solid tumors: Revised RECIST guideline (version 1.1).
        Eur J Cancer. 2009; 45: 228-247
        • Adachi Y.
        • Sakino I.
        • Matsumata T.
        • Iso Y.
        • Yoh R.
        • Kitano S.
        Clinical results and prognostic factors of radiologically node-positive gastric carcinoma.
        J Clin Gastroenterol. 1999; 28: 140-143
        • Bonomo L.
        • Ciccotosto C.
        • Guidotti A.
        • Storto M.L.
        Lung cancer staging: the role of computed tomography and magnetic resonance imaging.
        Eur J Radiol. 1996; 23: 35-45
        • Strauss G.M.
        • Herndon J.E.
        • Sherman D.D.
        • et al.
        Neoadjuvant chemotherapy and radiotherapy followed by surgery in stage IIIA non-small-cell carcinoma of the lung: report of a Cancer and Leukemia Group B phase II study.
        J Clin Oncol. 1992; 10: 1237-1244
        • Schnyder P.A.
        • Gamsu G.
        CT of the pretracheal retrocaval space.
        AJR. 1981; 136: 303-308
        • Dorfman R.E.
        • Alpern M.B.
        • Gross B.H.
        • Sandler M.A.
        Upper abdominal lymph nodes: criteria for normal size determined with CT.
        Radiology. 1991; 180: 319-322
        • Remy-Jardin M.
        • Duyck R.
        • Remy J.
        • et al.
        Hilar lymph nodes: identification with spiral CT and histologic correlation.
        Radiology. 1995; 196: 387-394
        • Kamiyoshihara M.
        • Kawashima O.
        • Ishikawa S.
        • Morishita Y.
        Mediastinal lymph node evaluation by computed tomographic scan in lung cancer.
        J Cardiovasc Surg (Torino). 2001; 42: 119-124
        • Kim S.H.
        • Kim S.C.
        • Choi B.I.
        • Han M.C.
        Uterine cervical carcinoma: evaluation of pelvic lymph node metastasis with MR imaging.
        Radiology. 1994; 190: 807-811
        • Arii K.
        • Takifuji K.
        • Yokoyama S.
        • et al.
        Preoperative evaluation of pelvic lateral lymph node of patients with lower rectal cancer: comparison study of MR imaging and CT in 53 patients.
        Langenbecks Arch Surg. 2006; 391: 449-454
        • van den Brekel M.W.M.
        • Castelijns J.A.
        • Snow G.B.
        Detection of lymph node metastases in the neck: radiologic criteria.
        Radiology. 1994; 192: 617-618
        • McLoud T.C.
        • Bourgouin P.M.
        • Greenberg R.W.
        • et al.
        Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling.
        Radiology. 1992; 182: 319-323
        • Dales R.E.
        • Stark R.M.
        • Raman S.
        Computed tomography to stage lung cancer. Approaching a controversy using meta-analysis.
        Am Rev Respir Dis. 1990; 141: 1096-1101
        • Fukuya T.
        • Honda H.
        • Hayashi T.
        • et al.
        Lymph-node metastases: efficacy for detection with helical CT in patients with gastric cancer.
        Radiology. 1995; 197: 705-711
        • Yang W.T.
        • Lam W.W.
        • Yu M.Y.
        • Cheung T.H.
        • Metreweli C.
        Comparison of dynamic helical CT and dynamic MR imaging in the evaluation of pelvic lymph nodes in cervical carcinoma.
        AJR Am J Roentgenol. 2000; 175: 759-766
        • Scher H.I.
        • Halabi S.
        • Tannock I.
        • et al.
        Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testerone: recommendations of the Prostate Cancer Clinical Trials Working Group.
        J Clin Oncol. 2008; 26: 1148-1159
        • Schwartz L.H.
        • Colville J.A.
        • Ginsberg M.S.
        • et al.
        Measuring tumor response and shape change on CT: esophageal cancer as a paradigm.
        Ann Oncol. 2006; 17: 1018-1023
        • Lewis E.
        • Bernardino M.E.
        • Salvador P.G.
        • Cabanillas F.F.
        • Barnes P.A.
        • Thomas J.L.
        Post-therapy CT-detected mass in lymphoma patients: is it viable tissue?.
        J Comput Assist Tomogr. 1982; 6: 792-795
        • Cheson B.D.
        • et al.
        • NCI Sponsored International Working Group
        Report of an international workshop to standardize response criteria for non-Hodgkin’s lymphomas.
        J Clin Oncol. 1999; 17: 1244
        • Cheson B.D.
        • Pfistner B.
        • Juewid M.
        • et al.
        Revised response criteria for malignant lymphoma.
        J Clin Oncol. 2007; 25: 579-586
        • Anzai Y.
        Superparamagnetic iron oxide nanoparticles: nodal metastases and beyond.
        Top Magn Reson Imaging. 2004; 15: 103-111
        • Mack M.G.
        • Balzer J.O.
        • Straub R.
        • Eichler K.
        • Vogl T.J.
        Superparamagnetic iron oxide-enhanced MR imaging of head and neck lymph nodes.
        Radiology. 2002; 222: 239-244
        • Kernstein K.
        • Stanford W.
        • Mullan B.F.
        • et al.
        PET, SV, and MRI with combidex for mediastinal staging in non-small cell lung carcinoma.
        Ann Thorac Surg. 1999; 68: 1022-1028